Roche Holding AG (RHHVF)
OTCMKTS · Delayed Price · Currency is USD
306.82
+5.09 (1.69%)
Aug 14, 2025, 9:30 AM EDT
Roche Holding AG Market Cap
Roche Holding AG has a market cap or net worth of $265.71 billion as of August 14, 2025. Its market cap has increased by 4.35% in one year.
Market Cap
265.71B
Enterprise Value
299.10B
Revenue
79.83B
Ranking
n/a
PE Ratio
22.41
Stock Price
$306.82
Market Cap Chart
Since January 2, 1992, Roche Holding AG's market cap has increased from 8.76B to 265.71B, an increase of 2,933.63%. That is a compound annual growth rate of 10.68%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 13, 2025 | 266.41B | 17.76% |
| Dec 30, 2024 | 226.23B | -3.34% |
| Dec 29, 2023 | 234.04B | -9.76% |
| Dec 30, 2022 | 259.35B | -22.73% |
| Dec 30, 2021 | 335.62B | 12.23% |
| Dec 30, 2020 | 299.05B | 8.13% |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Nika Pharmaceuticals | 972.72M |
| Veradigm | 806.69M |
| Tian'an Technology Group | 628.15M |
| Elite Pharmaceuticals | 610.23M |
| Glass House Brands | 560.80M |
| American Oncology Network | 385.65M |
| Northwest Biotherapeutics | 367.14M |
| CytoDyn | 300.75M |